Efficacy and tolerability of cefixime in otitis media. A multicentre study in over 25,000 children

D H Wu1

  • 1Lederle Laboratories, Pearl River, New York.

Drugs
|January 1, 1991
PubMed

Insights

Cefixime effectively treated acute otitis media in over 25,000 children, with 86% showing improvement. This antibiotic demonstrated good tolerability, making it a reliable option for pediatric ear infections.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Acute otitis media (AOM) is a common childhood infection.
  • Effective antibiotic treatment is crucial for managing AOM and preventing complications.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of cefixime in treating AOM in a large pediatric population.
  • To provide real-world data on cefixime's performance in a multicentre setting.

Main Methods:

  • A large-scale, multicentre clinical study involving 25,863 children diagnosed with AOM.
  • Children received a once-daily dosage of cefixime (8 mg/kg) for a minimum of 10 days.
  • Efficacy was assessed by cure or improvement rates, and tolerability by reported adverse effects.

Main Results:

  • 86% of children treated with cefixime experienced a cure or improvement of their AOM.
  • Adverse effects were reported in 11.5% of patients, with only 9.4% attributed to cefixime.
  • The efficacy and tolerability align with findings from controlled clinical trials.

Conclusions:

  • Cefixime is a highly effective treatment for acute otitis media in children.
  • The antibiotic is well-tolerated, supporting its use in pediatric practice.
  • This study confirms cefixime's role as a valuable therapeutic option for AOM.

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...